111 related articles for article (PubMed ID: 2043483)
1. Surface antigen expression of human neoplastic plasma cells includes molecules associated with lymphocyte recirculation and adhesion.
Hamilton MS; Ball J; Bromidge E; Franklin IM
Br J Haematol; 1991 May; 78(1):60-5. PubMed ID: 2043483
[TBL] [Abstract][Full Text] [Related]
2. Expression of adhesion molecules LFA-3 and N-CAM on normal and malignant human plasma cells.
Barker HF; Hamilton MS; Ball J; Drew M; Franklin IM
Br J Haematol; 1992 Jul; 81(3):331-5. PubMed ID: 1382543
[TBL] [Abstract][Full Text] [Related]
3. An analysis of myeloma plasma cell phenotype using antibodies defined at the IIIrd International Workshop on Human Leucocyte Differentiation Antigens.
Jackson N; Ling NR; Ball J; Bromidge E; Nathan PD; Franklin IM
Clin Exp Immunol; 1988 Jun; 72(3):351-6. PubMed ID: 3048803
[TBL] [Abstract][Full Text] [Related]
4. Normal and clonal B lineage cells can be distinguished by their differential expression of B cell antigens and adhesion molecules in peripheral blood from multiple myeloma (MM) patients--diagnostic and clinical implications.
Luque R; Brieva JA; Moreno A; Manzanal A; Escribano L; Villarrubia J; Velasco JL; López-Jiménez J; Cerveró C; Otero MJ; Martínez J; Bellas C; Roldán E
Clin Exp Immunol; 1998 Jun; 112(3):410-8. PubMed ID: 9649209
[TBL] [Abstract][Full Text] [Related]
5. CD19 and immunophenotype of bone marrow plasma cells in monoclonal gammopathy of undetermined significance.
Zandecki M; Facon T; Bernardi F; Izydorczyk V; Dupond L; François M; Reade R; Iaru T; Bauters F; Cosson A
J Clin Pathol; 1995 Jun; 48(6):548-52. PubMed ID: 7545187
[TBL] [Abstract][Full Text] [Related]
6. Cell surface markers in multiple myeloma.
Ruiz-Argüelles GJ; San Miguel JF
Mayo Clin Proc; 1994 Jul; 69(7):684-90. PubMed ID: 8015335
[TBL] [Abstract][Full Text] [Related]
7. Antigens on human plasma cells identified by monoclonal antibodies.
Anderson KC; Park EK; Bates MP; Leonard RC; Hardy R; Schlossman SF; Nadler LM
J Immunol; 1983 Mar; 130(3):1132-8. PubMed ID: 6401780
[TBL] [Abstract][Full Text] [Related]
8. A monoclonal antibody with reactivity restricted to normal and neoplastic plasma cells.
Anderson KC; Bates MP; Slaughenhoupt B; Schlossman SF; Nadler LM
J Immunol; 1984 Jun; 132(6):3172-9. PubMed ID: 6427334
[TBL] [Abstract][Full Text] [Related]
9. Flow cytometric immunophenotypic characteristics of plasma cell leukemia.
Kraj M; Kopeć-Szlęzak J; Pogłód R; Kruk B
Folia Histochem Cytobiol; 2011; 49(1):168-82. PubMed ID: 21526505
[TBL] [Abstract][Full Text] [Related]
10. Multiparameter analyses of normal and malignant human plasma cells: CD38++, CD56+, CD54+, cIg+ is the common phenotype of myeloma cells.
Leo R; Boeker M; Peest D; Hein R; Bartl R; Gessner JE; Selbach J; Wacker G; Deicher H
Ann Hematol; 1992 Mar; 64(3):132-9. PubMed ID: 1373957
[TBL] [Abstract][Full Text] [Related]
11. Establishment of a monoclonal antibody to plasma cells: a comparison with CD38 and PCA-1.
Hata H; Matsuzaki H; Matsuno F; Sonoki T; Takemoto S; Kuribayashi N; Nagasaki A; Takatsuki K
Clin Exp Immunol; 1994 May; 96(2):370-5. PubMed ID: 8187346
[TBL] [Abstract][Full Text] [Related]
12. Identification of malignant plasma cell precursors in the bone marrow of multiple myeloma.
Caligaris-Cappio F; Bergui L; Tesio L; Pizzolo G; Malavasi F; Chilosi M; Campana D; van Camp B; Janossy G
J Clin Invest; 1985 Sep; 76(3):1243-51. PubMed ID: 2931452
[TBL] [Abstract][Full Text] [Related]
13. Immunophenotypic analysis of lymphocytes and myeloma cells in patients with multiple myeloma.
Shimazaki C; Fried J; Perez AG; Scheinberg DA; Atzpodien J; Wang CY; Wisniewolski R; Clarkson BD
Acta Haematol; 1990; 83(3):123-9. PubMed ID: 2109450
[TBL] [Abstract][Full Text] [Related]
14. The CD24 antigen discriminates between pre-B and B cells in human bone marrow.
Duperray C; Boiron JM; Boucheix C; Cantaloube JF; Lavabre-Bertrand T; Attal M; Brochier J; Maraninchi D; Bataille R; Klein B
J Immunol; 1990 Dec; 145(11):3678-83. PubMed ID: 1700990
[TBL] [Abstract][Full Text] [Related]
15. Normal and neoplastic plasma cell membrane phenotype: studies with new monoclonal antibodies.
Tazzari PL; Gobbi M; Dinota A; Bontadini A; Grassi G; Cerato C; Cavo M; Pileri S; Caligaris-Cappio F; Tura S
Clin Exp Immunol; 1987 Oct; 70(1):192-200. PubMed ID: 3319299
[TBL] [Abstract][Full Text] [Related]
16. Very late antigen (VLA) expression by normal and neoplastic human plasma cells; including an assessment of antibodies submitted to the Vth International Workshop on Leucocyte Differentiation Antigens using human myeloma cell lines.
Drew M; Barker HF; Ball J; Pearson C; Cook G; Franklin I
Leuk Res; 1996 Jul; 20(7):619-24. PubMed ID: 8795696
[TBL] [Abstract][Full Text] [Related]
17. [Myeloma precursor cells].
Iwato K; Kawano MM
Rinsho Ketsueki; 1993 Apr; 34(4):433-8. PubMed ID: 7685432
[TBL] [Abstract][Full Text] [Related]
18. Immunophenotypic and genotypic characterisation of multiple myelomas with adverse prognosis characterised by immunohistological expression of the T cell related antigen CD45RO (UCHL-1).
Menke DM; Horny HP; Griesser H; Atkinson EJ; Kaiserling E; Kyle RA
J Clin Pathol; 1998 Jun; 51(6):432-7. PubMed ID: 9771441
[TBL] [Abstract][Full Text] [Related]
19. Expression of cytoadhesion molecules (CD56, CD54, CD18 and CD29) by myeloma plasma cells.
Van Riet I; De Waele M; Remels L; Lacor P; Schots R; Van Camp B
Br J Haematol; 1991 Nov; 79(3):421-7. PubMed ID: 1721526
[TBL] [Abstract][Full Text] [Related]
20. Multiple myeloma: relationship between light chain isotype suppression, labelling index of plasma cells, and CD38 expression on peripheral blood lymphocytes.
Joshua DE; Ioannidis R; Brown R; Francis SE; Gibson J; Kronenberg H
Am J Hematol; 1988 Sep; 29(1):5-11. PubMed ID: 3052044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
